Arch Development Partners
A venture capital and private equity firm investing in biotechnology, life science, wireless, software, and technology infrastructure companies.
All edits
As of November 2019, Arch Development Partners is no longer in operation, but over the course of its lifetime made 15 investments and 10 exits. Notable investments made by Arch Development Partners include: Mobitrac, Adeptia, AccelChip, Rubicon Genomics, SmartSignal, NephRx, and Zuchem.
As of November 2019, Arch Development Partners is no longer in operation, but over the course of its lifetime made 15 investments and 10 exits. Notable investments made by Arch Development Partners include: Mobitrac, Adeptia, AccelChip, Rubicon Genomics, SmartSignalSmartSignal, NephRx, and Zuchem.
Arch Development Partners is a venture capital and private equity firm investing in biotechnology, life science, wireless, software, and technology infrastructure companies that is headquartered in ChicagoChicago, Illinois and was founded in 2001 by Teri F. Willey.
As of November 2019, Arch Development Partners is no longer in operation, but over the course of its lifetime made 15 investments and 10 exits. Notable investments made by Arch Development Partners include: Mobitrac, Adeptia, AccelChip, Rubicon GenomicsRubicon Genomics, SmartSignal, NephRx, and Zuchem.
According to Pitchbook (asAs of November 2019), Arch Development Partners is no longer in operation, but over the course of its lifetime made 15 investments and 10 exits. Notable investments made by Arch Development Partners include: Mobitrac, Adeptia, AccelChip, Rubicon Genomics, SmartSignal, NephRx, and Zuchem.
Arch Development Partners
A venture capital and private equity firm investing in biotechnology, life science, wireless, software, and technology infrastructure companies.
Arch Development Partners is a venture capital and private equity firm investing in biotechnology, life science, wireless, software, and technology infrastructure companies that is headquartered in Chicago, Illinois and was founded in 2001 by Teri F. Willey.
According to Pitchbook (as of November 2019), Arch Development Partners is no longer in operation, but over the course of its lifetime made 15 investments and 10 exits. Notable investments made by Arch Development Partners include: Mobitrac, Adeptia, AccelChip, Rubicon Genomics, SmartSignal, NephRx, and Zuchem.
Find more companies like Arch Development Partners
